# Study to Determine the Pharmacokinetics of Product 0405

> **NCT02176577** · PHASE3 · WITHDRAWN · sponsor: **Fougera Pharmaceuticals Inc.**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Product 0405

## Key facts

- **NCT ID:** NCT02176577
- **Lead sponsor:** Fougera Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business Reasons
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176577, "Study to Determine the Pharmacokinetics of Product 0405". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02176577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*